Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics

Author： Froehlich Tanya E.   McGough James J.   Stein Mark A.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.2, 2010-02, pp. : 99-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

By Childress Ann C.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 309-325

Adis International

Access to resources Recommend Favorite

Pharmacological management of attention-deficit hyperactivity disorder

By Reeves Gloria   Schweitzer Julie  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1313-1320

Informa Healthcare

Access to resources Recommend Favorite

Dexmethylphenidate Extended Release: In Attention-Deficit Hyperactivity Disorder

By Robinson Dean M.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 661-668

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite